Samir Kaul, Director at Guardant Health, Inc. (GH), sold 7,700 shares at $140.04 ($1.1M) on 2021-05-05, disclosed to the SEC on 2021-05-07.
Open-market sale of $1.1M GH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.04 | 1,295 | $181K | 16.5% |
| 2 | $140.04 | 1,295 | $181K | 16.5% |
| 3 | $141.64 | 300 | $42K | 3.9% |
| 4 | $142.62 | 500 | $71K | 6.5% |
| 5 | $143.49 | 1,405 | $202K | 18.4% |
| 6 | $143.49 | 1,405 |
| $202K |
| 18.4% |
| 7 | $144.50 | 900 | $130K | 11.9% |
| 8 | $145.18 | 300 | $44K | 4.0% |
| 9 | $146.27 | 300 | $44K | 4.0% |
| Total | $142.49 avg | 7,700 | $1.1M | 100% |
| Filing → |
| GH | SELL | 2020-09-21 | $1.8M | — | Filing → |
| GH | SELL | 2020-08-19 | $1.7M | — | Filing → |
| GH | SELL | 2020-03-06 | $2.1M | — | Filing → |